Aspira Pathlab & Diagnostics Ltd — Board Meeting, 16-05-2025: Board Meeting

Aspira Pathlab & Diagnostics Limited has announced a board meeting on May 16, 2025, where it approved the financial results for the quarter and half-year ended March 31, 2025, with an unmodified auditor’s opinion. The company appointed M/s. Nilesh A. Pradhan & Co. LLP as Secretarial Auditor for five years and M/s. Vishal J Bhanushali & Associates as Internal Auditor for 2025-26. The Board approved re-appointment of Dr. Pankaj Shah as Managing Director & CEO for three years from August 1, 2025, subject to shareholder approval. A postal ballot notice and related dates were also approved for the re-appointment. The standalone financials showed total income of Rs. 2,238.79 lakh and profit after tax of Rs. 207.26 lakh for the year, a turnaround from the prior year’s loss. The consolidated results including an associate reported total income of Rs. 2,238.79 lakh and profit after tax of Rs. 202.26 lakh. Cash flows remained healthy with net cash generated from operations of Rs. 187.70 lakh standalone and Rs. 182.71 lakh consolidated. The company’s pathology services constitute its sole business segment.